QTTB
Q32 Bio Inc.
NASDAQ · Healthcare · Biotechnology · US
$11.99
−6.33%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 713.87x
Trailing multiples
Trailing twelve months
- P/E TTM
- 4.30x
- PEG TTM
- —
- Price / book
- 3.37x
- Price / sales
- 6.64x
- Price / cash flow
- -18.00x
Enterprise value
- Enterprise value
- $256.0M
- EV / sales
- 4.76x
- EV / EBITDA
- 7.39x
- EV / EBIT
- 11.93x
- Market cap
- $356.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026